The short bowel syndrome market is poised for significant change, with next-generation GLP-2 analogues such as apraglutide (Ironwood Pharmaceuticals), glepaglutide (Zealand Pharma), and sonefpeglutide (Hanmi Pharmaceutical), among others, expected to enter the market from 2026….
Fujifilm joins C2PA and CAI content authentication organizations
Tucked away at the bottom of Fujifilm’s GFX 100S II press release is the news that Fujifilm …
Painting – Rendering in Colored Pencil
Painting – Rendering in Colored Pencil – a Culture interest event taking place on …
House break-in suspect arrested in Selcourt-Springs
Any homeowner worried about security should secure their perimeter first as this is your first line …